文献速递心脏核医学

瑞加腺苷负荷SPECT心肌灌注显像的预后价值:迄今最大队列研究

The prognostic value of regadenoson SPECT myocardial perfusion imaging: The largest cohort to date.
PubMed 文献 · J Nucl Cardiol · 2020-05-07

该单中心回顾性队列纳入10,275例连续接受瑞加腺苷负荷SPECT心肌灌注显像的患者,平均随访2.4±2.2年,主要终点为主要不良心脏事件(MACE,定义为心源性死亡或心肌梗死)。灌注异常与心肌缺血的存在及严重程度均与MACE独立相关,并在临床协变量和左心室射血分数之外提供增量预后信息;短暂性缺血性扩张≥1.31未提供增量预后价值。

要点

  • 灌注异常(校正HR 1.52;95%CI 1.21–1.91)与心肌缺血(校正HR 1.53;95%CI 1.25–1.89)均独立关联MACE。
  • 随灌注异常负荷和心肌缺血负荷增加,MACE呈显著逐步升高(P<.001)。
  • 负荷后LVEF、LVEF储备和左心室舒张末期容积提供显著预后信息;短暂性缺血性扩张≥1.31无增量价值(校正HR 1.02;P=.906)。

核心结论

  • 在迄今最大队列中,瑞加腺苷负荷SPECT心肌灌注显像所示灌注异常和心肌缺血的存在与严重程度与MACE独立增加相关。

研究设计与样本

  • 单中心、回顾性队列研究,纳入10,275例连续接受瑞加腺苷负荷SPECT心肌灌注显像的患者。
  • 患者平均随访2.4±2.2年,主要终点为MACE,定义为心源性死亡或心肌梗死。

主要发现

  • 28.7%的患者心肌灌注显像异常,25.5%的患者存在心肌缺血。
  • 随灌注异常负荷增加(P<.001)和心肌缺血负荷增加(P<.001),MACE呈显著逐步升高。
  • 心肌灌注显像异常与MACE相关(校正HR 1.52;95%CI 1.21–1.91),独立于并增量于临床协变量和左心室射血分数。
  • 心肌缺血与MACE相关(校正HR 1.53;95%CI 1.25–1.89),独立于并增量于临床协变量和左心室射血分数。
  • 负荷后左心室射血分数、左心室射血分数储备和左心室舒张末期容积提供显著预后信息;短暂性缺血性扩张≥1.31未提供增量预后价值(校正HR 1.02;P=.906)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data on the prognostic value of regadenoson SPECT myocardial perfusion imaging (MPI) is limited and based on small cohorts. METHODS AND RESULTS: We conducted a single-center, retrospective cohort study of 10,275 consecutive patients who underwent regadenoson SPECT-MPI. Among the study subjects, 28.7% had abnormal MPI and 25.5% had myocardial ischemia. Patients were followed for a mean of 2.4 ± 2.2 years for major adverse cardiac events (MACE), defined as cardiac death or myocardial infarction. There was a significant stepwise increase in MACE with an increasing burden of perfusion abnormality (P < .001) and myocardial ischemia (P < .001). Abnormal MPI (adjusted HR 1.52; 95% CI 1.21 to 1.91) and myocardial ischemia (adjusted HR 1.53; 95% CI 1.25 to 1.89) were associated with MACE, independent of and incremental to clinical covariates and left ventricular ejection fraction (LVEF). Moreover, post-stress LVEF, LVEF reserve, and left ventricular end-diastolic volume added significant prognostic information. Transient ischemic dilation ≥ 1.31 did not provide incremental prognostic value (adjusted HR 1.02; P = .906). CONCLUSION: In the largest cohort to date, we demonstrated that the presence and severity of perfusion abnormality and myocardial ischemia on regadenoson stress SPECT-MPI are associated with an independent increase in MACE.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Kattoor AJ, Kolkailah AA, Iskander F, et al. The prognostic value of regadenoson SPECT myocardial perfusion imaging: The largest cohort to date. J Nucl Cardiol. 2020. PMID: 32383079. doi:10.1007/s12350-020-02135-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。